Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.

Senate Draft Cosmetics Bill Mandates GMPs, Lets HHS Suspend Facilities

March 08, 2018
The Senate health committee sent stakeholders a draft of its cosmetics bill, obtained by Inside Health Policy , in a bid to gather input on the proposed federal oversight reforms, which include allowing HHS to suspend facilities or an ingredient listing, requiring manufacturers to report adverse events to HHS within a set period of time, mandating manufacturing and processing facilities register with HHS, establishing labeling requirements, and allowing HHS to inspect facility records if it believes a cosmetic product is...